|
US5958930A
(en)
|
1991-04-08 |
1999-09-28 |
Duquesne University Of The Holy Ghost |
Pyrrolo pyrimidine and furo pyrimidine derivatives
|
|
WO1997049706A1
(en)
*
|
1996-06-25 |
1997-12-31 |
Novartis Ag |
SUBSTITUTED 7-AMINO-PYRROLO[3,2-d]PYRIMIDINES AND THE USE THEREOF
|
|
US20080248046A1
(en)
|
1997-03-17 |
2008-10-09 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
|
AR035885A1
(es)
*
|
2001-05-14 |
2004-07-21 |
Novartis Ag |
Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica
|
|
DE60228103D1
(de)
|
2001-10-02 |
2008-09-18 |
Smithkline Beecham Corp |
Chemische verbindungen
|
|
DE10239042A1
(de)
|
2002-08-21 |
2004-03-04 |
Schering Ag |
Makrozyclische Pyrimidine, deren Herstellung und Verwendung als Arzneimittel
|
|
WO2004106339A2
(en)
|
2003-05-28 |
2004-12-09 |
Università Degli Studi Di Siena |
4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-d] PYRIMIDINE AND PYRROLO [2,3-d] PYRIMIDINE AND USES THEREOF
|
|
US7504396B2
(en)
|
2003-06-24 |
2009-03-17 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
|
GB0320728D0
(en)
|
2003-09-04 |
2003-10-08 |
Kilminster Shaun |
Test
|
|
BRPI0414533A
(pt)
|
2003-09-18 |
2006-11-07 |
Conforma Therapeutics Corp |
composto, composição farmacêutica, e, métodos para inibir um hsp90 e para tratar um indivìduo tendo um distúrbio mediado por hsp90
|
|
EP2233174B1
(en)
|
2004-01-21 |
2016-07-20 |
Emory University |
Compositions and use of tyrosine kinase inhibitors to treat pathogenic infection
|
|
CA2553724A1
(en)
|
2004-02-03 |
2005-08-18 |
Abbott Laboratories |
Aminobenzoxazoles as therapeutic agents
|
|
US7968557B2
(en)
*
|
2004-02-14 |
2011-06-28 |
Novartis Ag |
Substituted pyrrolo[2,3-2]pyrimidines as protein kinase inhibitors
|
|
EP1749827A4
(en)
|
2004-03-30 |
2010-04-21 |
Kyowa Hakko Kirin Co Ltd |
ANTITUMOR AGENTS
|
|
WO2005099688A2
(en)
*
|
2004-04-07 |
2005-10-27 |
Takeda Pharmaceutical Company Limited |
Cyclic compounds
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
EP1797069B1
(en)
|
2004-09-30 |
2011-08-17 |
Tibotec Pharmaceuticals |
Hiv inhibiting 5-heterocyclyl pyrimidines
|
|
WO2006042102A2
(en)
*
|
2004-10-05 |
2006-04-20 |
Neurogen Corporation |
Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds
|
|
EP1710246A1
(en)
|
2005-04-08 |
2006-10-11 |
Schering Aktiengesellschaft |
Sulfoximine-pyrimidine Macrocycles and the salts thereof, a process for making them, and their pharmaceutical use against cancer
|
|
EP1937258A2
(en)
*
|
2005-09-23 |
2008-07-02 |
Conforma Therapeutics Corporation |
Anti-tumor methods using multi drug resistance independent synthetic hsp90 inhibitors
|
|
US7547782B2
(en)
|
2005-09-30 |
2009-06-16 |
Bristol-Myers Squibb Company |
Met kinase inhibitors
|
|
CN101321759A
(zh)
|
2005-10-06 |
2008-12-10 |
先灵公司 |
作为蛋白激酶抑制剂的吡唑并嘧啶化合物
|
|
EA017812B1
(ru)
|
2005-12-08 |
2013-03-29 |
Медарекс, Инк. |
Выделенное моноклональное антитело или его антигенсвязывающий участок, которые связываются с протеинтирозинкиназой 7 ( ptk7) человека, и их применение
|
|
EP1979002A2
(en)
|
2005-12-19 |
2008-10-15 |
OSI Pharmaceuticals, Inc. |
Combination of igfr inhibitor and anti-cancer agent
|
|
EP1803723A1
(de)
|
2006-01-03 |
2007-07-04 |
Bayer Schering Pharma Aktiengesellschaft |
(2,4,9-triaza-1(2,4)-pyrimidina-3(1,3)-benzenacyclononaphan-3^4-yl)-sulfoximid derivate als selektive inhibitoren der aurora kinase zur behandlung von krebs
|
|
CN101405283B
(zh)
|
2006-03-30 |
2014-06-18 |
泰博特克药品有限公司 |
Hiv抑制性5-酰氨基取代的嘧啶类化合物
|
|
WO2007125405A2
(en)
|
2006-05-01 |
2007-11-08 |
Pfizer Products Inc. |
Substituted 2-amino-fused heterocyclic compounds
|
|
GB0610242D0
(en)
|
2006-05-23 |
2006-07-05 |
Novartis Ag |
Organic compounds
|
|
JO3235B1
(ar)
|
2006-05-26 |
2018-03-08 |
Astex Therapeutics Ltd |
مركبات بيررولوبيريميدين و استعمالاتها
|
|
AU2008296479A1
(en)
|
2007-08-28 |
2009-03-12 |
Dana Farber Cancer Institute |
Amino substituted pyrimidine, pyrollopyridine and pyrazolopyrimidine derivatives useful as kinase inhibitors and in treating proliferative disorders and diseases associated with angiogenesis
|
|
HRP20110470T1
(hr)
|
2007-10-12 |
2011-07-31 |
Ingenium Pharmaceuticals Gmbh |
Inhibitori proteinskih kinaza
|
|
WO2010008411A1
(en)
*
|
2007-11-09 |
2010-01-21 |
The Salk Institute For Biological Studies |
Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
US8399206B2
(en)
|
2008-07-10 |
2013-03-19 |
Nodality, Inc. |
Methods for diagnosis, prognosis and methods of treatment
|
|
US20120230991A1
(en)
|
2008-07-29 |
2012-09-13 |
Douglas Kim Graham |
Methods and compounds for enhancing anti-cancer therapy
|
|
US8569466B2
(en)
|
2008-09-10 |
2013-10-29 |
Nnochiri Ekwuribe |
Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers
|
|
UY32158A
(es)
|
2008-10-03 |
2010-04-30 |
Astrazeneca Ab |
Derivados heterociclicos y metodos de uso de los mismos
|
|
GB0819105D0
(en)
*
|
2008-10-17 |
2008-11-26 |
Chroma Therapeutics Ltd |
Pyrrolo-pyrimidine compounds
|
|
US8513242B2
(en)
|
2008-12-12 |
2013-08-20 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Pyrimidine compounds and methods of making and using same
|
|
US8765727B2
(en)
|
2009-01-23 |
2014-07-01 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
|
TW201102391A
(en)
*
|
2009-03-31 |
2011-01-16 |
Biogen Idec Inc |
Certain substituted pyrimidines, pharmaceutical compositions thereof, and methods for their use
|
|
UA107791C2
(en)
|
2009-05-05 |
2015-02-25 |
Dow Agrosciences Llc |
Pesticidal compositions
|
|
AR076550A1
(es)
|
2009-05-06 |
2011-06-22 |
Portola Pharm Inc |
Inhibidores de la janus tirosina kinasa (jak)
|
|
EP3381937A3
(en)
|
2009-08-13 |
2018-10-31 |
The Johns Hopkins University |
Methods of modulating immune function
|
|
AU2010294209A1
(en)
*
|
2009-09-10 |
2012-03-29 |
Irm Llc |
Ether derivatives of bicyclic heteroaryls
|
|
WO2011065800A2
(ko)
|
2009-11-30 |
2011-06-03 |
주식회사 오스코텍 |
피리미딘 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
|
|
US9433621B2
(en)
|
2010-02-18 |
2016-09-06 |
Merck Sharp & Dohme Corp. |
Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
|
|
GB201004311D0
(en)
|
2010-03-15 |
2010-04-28 |
Proximagen Ltd |
New enzyme inhibitor compounds
|
|
WO2011133920A1
(en)
|
2010-04-23 |
2011-10-27 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
|
WO2011146313A1
(en)
*
|
2010-05-19 |
2011-11-24 |
The University Of North Carolina At Chapel Hill |
Pyrazolopyrimidine compounds for the treatment of cancer
|
|
WO2011153553A2
(en)
|
2010-06-04 |
2011-12-08 |
The Regents Of The University Of California |
Methods and compositions for kinase inhibition
|
|
JP2014005206A
(ja)
|
2010-10-22 |
2014-01-16 |
Astellas Pharma Inc |
アリールアミノヘテロ環カルボキサミド化合物
|
|
AU2011330730B2
(en)
|
2010-11-18 |
2016-02-18 |
Kasina Laila Innova Pharmaceuticals Private Limited |
Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof
|
|
US8362023B2
(en)
|
2011-01-19 |
2013-01-29 |
Hoffmann-La Roche Inc. |
Pyrazolo pyrimidines
|
|
US9376438B2
(en)
|
2011-05-17 |
2016-06-28 |
Principia Biopharma, Inc. |
Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
|
|
AU2012302197B2
(en)
|
2011-08-29 |
2016-01-07 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
|
JP5914667B2
(ja)
*
|
2011-09-22 |
2016-05-11 |
ファイザー・インク |
ピロロピリミジンおよびプリン誘導体
|
|
AU2012318896B2
(en)
|
2011-10-03 |
2017-03-02 |
The University Of North Carolina At Chapel Hill |
Pyrrolopyrimidine compounds for the treatment of cancer
|
|
US20160015808A1
(en)
|
2012-02-21 |
2016-01-21 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Tam receptors as virus entry cofactors
|
|
IN2012CH01573A
(enExample)
|
2012-04-20 |
2015-07-10 |
Advinus Therapeutics Ltd |
|
|
US9567326B2
(en)
|
2012-05-22 |
2017-02-14 |
The University Of North Carolina At Chapel Hill |
Pyrimidine compounds for the treatment of cancer
|
|
WO2014062774A1
(en)
|
2012-10-17 |
2014-04-24 |
The University Of North Carolina At Chapel Hill |
Pyrazolopyrimidine compounds for the treatment of cancer
|
|
WO2014085225A1
(en)
|
2012-11-27 |
2014-06-05 |
The University Of North Carolina At Chapel Hill |
Pyrimidine compounds for the treatment of cancer
|
|
US20170202847A1
(en)
|
2014-04-04 |
2017-07-20 |
The University Of North Carolina At Chapel Hill |
Methods for the treatment of tumors
|
|
US20150291606A1
(en)
|
2014-04-11 |
2015-10-15 |
The University Of North Carolina At Chapel Hill |
Mertk-specific pyrrolopyrimidine compounds
|